Qube Research & Technologies LTD Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Qube Research & Technologies LTD

  • $61.9 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $81.9 Million - $90.1 Million
90,700 Added 1971.74%
95,300 $91.7 Million
Q4 2023

Feb 13, 2024
SELL
$775.18 - $881.7 $9.84 Million - $11.2 Million
-12,700 Reduced 73.41%
4,600 $4.04 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $12 Million - $14.6 Million
17,300 New
17,300 $14.2 Million

Others Institutions Holding REGN

# of Institutions
1,424
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email